Clinical Trial Update: 3mg Liraglutide for Overweight or Obesity

View source ↗

Summary

A completed clinical trial evaluated 3 mg liraglutide for overweight or obesity. The study also noted infertility in females as a condition of interest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Obesity
• Overweight

Drugs mentioned

• Saxenda (liraglutide) (liraglutide)

Snippet

Sponsor: University Hospitals Coventry and Warwickshire NHS Trust | Conditions: Overweight, Obesity | Status: COMPLETED